Diaceutics Regulatory News (DXRX)

Diaceutics PLC

("Diaceutics" or the "Company")

Dublin investor presentation

Diaceutics PLC (AIM: DXRX), the data analytics and implementation services company which services the global pharmaceutical industry, announces it will hold an investor presentation in Dublin, Ireland on Tuesday, 29 October 2019.

The investor event will take place at a city centre hotel in Dublin, and will commence at 4.45pm for a 5pm start. This will be followed by drinks and canapés, and a chance to network with the management.

Peter Keeling, CEO, will provide an introduction to the Company and an overview of the business, as well as an update on the recently published maiden set of results since the IPO in March.

If you would like to register to attend the investor briefing or require further information, please contact Walbrook PR on +44 (0) 20 7933 8780 or email diaceutics@walbrookpr.com.

No new material information will be disclosed at the event.

Enquiries:

About Diaceutics

Diaceutics PLC is a leading diagnostics data analytics and implementation services provider for global pharmaceutical companies. The Company, quoted on the Alternative Investment Market (AIM) of the London Stock Exchange, is enabling Pharma to accelerate their market penetration and achieve a better return on precision medicine therapies by helping them to revolutionise patient testing. By generating insights from its data lake of clinical laboratory testing data and other data, Diaceutics helps Pharma understand and leverage the diagnostic landscape through initiatives that improve patient testing, leading to better treatment outcomes. The Company works with more than 30 global pharmaceutical companies across hundreds of precision medicine projects. The Company employs a leading global group of experts from the laboratory, diagnostic and pharmaceutical industries. www.diaceutics.com